Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_1

25%

Ph phase_2

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

Phase 1Safety & dosage

1(50.0%)

Phase 2Efficacy & side effects

1(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Detailed Status

Completed3

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 11 (50.0%)

Phase 21 (50.0%)

Trials by Status

withdrawn125%

completed375%

Recent Activity

0 active trials

Showing 4 of 4

completed

Population Pharmacokinetics of Antiepileptic in Pediatrics

NCT03196466

completed

Pathophysiology of Tremor-modulating Mechanisms of Propranolol and Primidone in Essential Tremor

NCT04692844

withdrawnphase_2

Effect of Primidone on Platelet Responsiveness in Patients Determined to be Clopidogrel Resistant

NCT02008123

completedphase_1

Bioequivalence Study of Primidone Tablets 50 mg of Dr. Reddy's Under Fasting Conditions

NCT01132040

Clinical Trials (4)

Showing 4 of 4 trials

NCT03196466

Population Pharmacokinetics of Antiepileptic in Pediatrics

Completed

NCT04692844

Pathophysiology of Tremor-modulating Mechanisms of Propranolol and Primidone in Essential Tremor

Completed

NCT02008123Phase 2

Effect of Primidone on Platelet Responsiveness in Patients Determined to be Clopidogrel Resistant

Withdrawn

NCT01132040Phase 1

Bioequivalence Study of Primidone Tablets 50 mg of Dr. Reddy's Under Fasting Conditions

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4